0 Kommentare
0 Anteile
486 Ansichten
Search
Entdecken Sie neue Leute, neue Verbindungen zu schaffen und neue Freundschaften
- FAVORITEN
-
- EXPLORE
-
-
-
-
-
-
-
- Please log in to like, share and comment!
- Disease Model Customization Accelerates Preclinical GI and Hepatology ResearchAce Therapeutics is a preclinical contract research provider engaged in metabolic disorders, infectious diseases and parasites, neurological disorders, ophthalmic diseases, gastrointestinal disorders, and immune system diseases. Following with the announcement of developing small molecule drug for glaucoma, Ace Therapeutics recently unveiled disease model customization services to accelerate...0 Kommentare 0 Anteile 1621 Ansichten
- Next-Generation Drug Delivery Technologies for GlaucomaAce Therapeutics is a preclinical contract research provider engaged in ophthalmic diseases. To help pharmaceutical partners and academic institutions overcome the challenges of low bioavailability and unsustainable drug release in drug formations for glaucoma, Ace Therapeutics is proud to announce the unveiling of its cutting-edge drug delivery system development services for the treatment of...0 Kommentare 0 Anteile 1675 Ansichten
- Unlock the Potential of Diabetic Mouse Models in Preclinical Diabetes ResearchAce Therapeutics Diabetes, a leading provider of preclinical research services and products, is proud to announce the launch of its extensive suite of diabetic mouse models. These models have been specifically designed to enable research on different types of diabetes including type 1, type 2, and gestational diabetes, providing valuable insights into disease mechanisms and potential treatment...0 Kommentare 0 Anteile 395 Ansichten
- Vaccine Development Technologies Aid in Addressing Superbugs ThreatAce Therapeutics is a preclinical contract research provider engaged in metabolic disorders, infectious diseases and parasites, neurological disorders, ophthalmic diseases, gastrointestinal disorders, and immune system diseases. With the rise of antibiotic-resistant bacteria posing a significant threat to global public health, Ace Therapeutics announces its new vaccine development services to...0 Kommentare 0 Anteile 3730 Ansichten